Yogendra Nayak

BPharm, MPharm (Pharmacology), PhD

Associate Professor, Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal
Coordinator, Centre for Research on Research
Admin, PURE Portal, Directorate of Research

https://orcid.org/0000-0002-0508-1394

Phone+918202922482 Ext 326, +919448154003
Emailyogendra.nayak@manipal.edu
Websitehttps://manipal.edu/mcops-manipal/department-faculty/faculty-list/yogendra-nayak/_jcr_content.html

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Interests

Preclinical Pharmacology, Pharmaceutical Education, Bibliometrics and Scientometrics

Experience

Fifteen years of experience in academia and research. The academic strenght is abilities to learn and implement the new technological innovations in pedagogy. Interested in Pharmacy Education, Pharmacy Profession, Preclincal Pharmacology, Research Methodologies, Bibliometrics and Scienctometrics

Education/Academic qualification

Manipal Academy of Higher Education, Manipal

Award Date: 06-07-2011

Manipal College of Pharmaceutical Sciences, Manipal

Award Date: 12-01-1997

Government College of Pharmacy, Bangalore, India

External positions

Fingerprint

Dive into the research topics where Yogendra Nayak is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

384 Citations
11 h-Index
35 Article
3 Review article
2 Chapter
1 Letter

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study
Baby, K., Maity, S., Mehta, C. H., Suresh, A., Nayak, U. Y. & Nayak, Y., 05-04-2021, In: European Journal of Pharmacology. 896, 173922.
Research output: Contribution to journal › Article › peer-review
Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance
Maity, S., Pai, K. S. R. & Nayak, Y., 01-08-2020, In: Pharmacological Reports.
Research output: Contribution to journal › Review article › peer-review

Open Access
1 Citation (Scopus)
Combination therapy and nanoparticulate systems: Smart approaches for the effective treatment of breast cancer
Gadag, S., Sinha, S., Nayak, Y., Garg, S. & Nayak, U. Y., 06-2020, In: Pharmaceutics. 12, 6, p. 1-37 37 p., 524.
Research output: Contribution to journal › Review article › peer-review

Open Access
1 Citation (Scopus)
In silico drug repurposing of penicillins to target main protease mpro of SARS-CoV-2
Baby, K., Maity, S., Mehta, C., Suresh, A., Nayak, U. Y. & Nayak, Y., 11-2020, In: Pharmaceutical Sciences. 26, p. S52-S62
Research output: Contribution to journal › Article › peer-review
1 Citation (Scopus)
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study
Baby, K., Maity, S., Mehta, C. H., Suresh, A., Nayak, U. Y. & Nayak, Y., 2020, (Accepted/In press) In: Archives of Medical Research.
Research output: Contribution to journal › Article › peer-review
6 Citations (Scopus)

Research Interests

Experience

Education/Academic qualification

External positions

SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study

Advances in targeting EGFR allosteric site as anti-NSCLC therapy to overcome the drug resistance

Combination therapy and nanoparticulate systems: Smart approaches for the effective treatment of breast cancer

In silico drug repurposing of penicillins to target main protease mpro of SARS-CoV-2

Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study